Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.

Jiang DK, Yao L, Ren WH, Wang WZ, Peng B, Yu L.

Med Oncol. 2011 Dec;28(4):1129-35. doi: 10.1007/s12032-010-9597-x.

PMID:
20552298
2.

Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.

Shen SQ, Jiang DK, Liu GY, Chen F, Yu L.

Mol Biol Rep. 2012 Apr;39(4):4683-90. doi: 10.1007/s11033-011-1260-x.

PMID:
21952824
3.

Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.

Wang B, Wang D, Zhang D, Li A, Liu D, Liu H, Jin H.

Eur J Cancer Prev. 2010 Jul;19(4):299-307. doi: 10.1097/CEJ.0b013e32833964bc.

PMID:
20389250
4.

Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.

Xiang B, Mi YY, Li TF, Liu PF.

Asian Pac J Cancer Prev. 2012;13(5):1787-91.

5.

TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.

Jiang DK, Yao L, Wang WZ, Peng B, Ren WH, Yang XM, Yu L.

World J Gastroenterol. 2011 Mar 7;17(9):1227-33. doi: 10.3748/wjg.v17.i9.1227.

6.

No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.

Ma Y, Yang J, Liu Z, Zhang P, Yang Z, Wang Y, Qin H.

Breast Cancer Res Treat. 2011 Jan;125(1):201-5. doi: 10.1007/s10549-010-0920-1.

PMID:
20496166
7.

P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians.

Xu T, Xu ZC, Zou Q, Yu B, Huang XE.

Asian Pac J Cancer Prev. 2012;13(5):2349-54.

8.

The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: a meta-analysis including 7,107 subjects.

Yang X, Yang B, Liu Y, Xu S, Li B.

Indian J Dermatol. 2013 May;58(3):175-80. doi: 10.4103/0019-5154.110823.

9.

Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk.

Gu Y, Zhou X, Zhang SL.

Genet Mol Res. 2011 Oct 31;10(4):3609-19. doi: 10.4238/2011.October.31.11.

10.

Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.

Chen MB, Li C, Shen WX, Guo YJ, Shen W, Lu PH.

Mol Biol Rep. 2011 Oct;38(7):4687-95. doi: 10.1007/s11033-010-0603-3.

PMID:
21127985
11.
12.

Lack of association between p53 codon 72 polymorphism and endometrial cancer: a meta-analysis.

Tang W, He X, Chan Y, Luo Y.

Cancer Epidemiol. 2012 Jun;36(3):e153-7. doi: 10.1016/j.canep.2011.12.010.

PMID:
22277327
13.

Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies.

Ren WH, Jiang DK, Pei Y, Wang SQ, Yang XM, Yu L.

Genet Mol Res. 2014 Jan 8;13(1):103-14. doi: 10.4238/2014.January.8.9.

14.
15.

TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.

Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Dong JH, Zhang L, Xu J, Shi W, Ren YC.

Mol Biol Rep. 2011 Nov;38(8):4847-53. doi: 10.1007/s11033-010-0619-8.

PMID:
21140221
16.

Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.

Ye J, Li XF, Wang YD, Yuan Y.

PLoS One. 2013 Nov 8;8(11):e79983. doi: 10.1371/journal.pone.0079983.

17.

Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.

Liu ZH, Bao ED.

Mol Biol Rep. 2013 Mar;40(3):2389-95. doi: 10.1007/s11033-012-2319-z.

PMID:
23184052
18.

The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian women.

Zubor P, Stanclova A, Kajo K, Hatok J, Klobusiakova D, Visnovsky J, Danko J.

Oncology. 2009;76(3):173-83. doi: 10.1159/000201570.

PMID:
19209008
19.

XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.

Liu F, Li B, Wei Y, Yan L, Wen T, Zhao J, Xu M.

Liver Int. 2011 Jul;31(6):802-9. doi: 10.1111/j.1478-3231.2011.02508.x. Review.

PMID:
21645210
20.

No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.

Jiang N, Pan J, Wang L, Duan YZ.

Tumour Biol. 2013 Feb;34(1):587-96. doi: 10.1007/s13277-012-0587-9.

PMID:
23192640
Items per page

Supplemental Content

Support Center